1996
Fresenius Medical Care is founded from a merger of Fresenius Worldwide Dialysis and National Medical Care. The company’s shares are listed at the stock exchanges in Frankfurt and New York.
1999
The 100,000thth dialysis machine comes off the production line.
Fresenius Medical Cares’ ordinary share is admitted to the DAX, Germany’s blue-chip share index.
2003
Fresenius Medical Care is the leading dialysis company caring for more than 119,000 patients in own dialysis centers worldwide. With a production output of more than 50 million dialyzers per year the company sets a new record.
2005
The new dialysis therapy system 5008 is introduced in the market and wins the prize “Innovationspreis der Deutschen Wirtschaft”.
2012
Fresenius Medical Care produces the 500,000thth dialysis machine.
2014
A new generation of home dialysis cyclers is launched – sleep•safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy.
2016
Launch of the 6008 CAREsystem, a new hemodialysis therapy system, , that delivers advanced dialysis therapy more easily, leaving more time for direct patient care.
2018
Fresenius Medical Care launches the 4008A dialysis machine tailored to needs in emerging markets.
2019
By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home dialysis offering patients greater flexibility.
2020
Launch of the Global Sustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years.
Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth.
Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth.
2021
Celebrating our 25th anniversary, as the world's leading provider of products and services for individuals with renal diseases.